The pooled sensitivity of BALF pentraxin 3 for diagnosis of respiratory tract infections was 0.85 (95% CI, 0.78–0.90) and the pooled specificity was 0.80 (95% CI, 0.76–0.84; Fig. 8). This evidence concerns the gene PTX3 and Respiratory tract infection.